Dr. Vaibhav Madhukar Anvekar, MD

Dr. Anvekar practices at Huntington Hospital - Unit in Pasadena, California.

Dr. Anvekar's NPI, 1366548307, was assigned on September 16, 2006. Dr. Anvekar graduated from Keck School of Medicine of USC in 1998. Dr. Anvekar holds California license A71040.

Dr. Anvekar's primary practice is Huntington Hospital - Unit, at 100 W. California Blvd, Pasadena, CA 91105 in Los Angeles County. The practice phone is (626) 397-2618.

Dr. Anvekar's primary practice is Huntington Hospital - Unit in Pasadena, California. Dr. Anvekar is also affiliated with Huntington Hospital. The medical group on file is Cedars-Sinai Medical Group. Dmand AI also links Dr. Anvekar to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Anvekar practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Anvekar's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Anvekar is board certified in internal medicine by the American Board of Internal Medicine. Dr. Anvekar is licensed in California.

Dmand AI lists acute diabetes, anemia, bile duct problems, cellulitis, circulation problems, congestive heart failure, electrolyte disorders and gastrointestinal bleeding among the conditions Dr. Anvekar treats.

CMS data shows 905 Medicare services from Dr. Anvekar across 3 procedure codes in 2024, for 326 Medicare patients. Medicare paid $64,410 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 326 Medicare patients who saw Dr. Anvekar in 2024. The largest group is 75 to 84, with 107 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 47% are also on Medicaid. Their average risk score is 2.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Anvekar's median patient age at 61, with 50% women.

In 2024, Dr. Anvekar wrote 273 Medicare Part D claims for 113 patients. 86% of them were for generic drugs. CMS names the drug for 78 of them, across 6 drugs with 11 or more claims each, at $9,139 in total drug cost. In 2023, CMS named 54 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Anvekar for performance year 2024, reported as part of a group. Dr. Anvekar accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 50 general payments to Dr. Anvekar from 14 drug and device companies from 2016 to 2021. Consulting fees make up the largest share, 72% of the total. Pfizer Inc. paid the most, $2,371.

Dr. Anvekar graduated from Keck School of Medicine of USC in 1998. Dr. Anvekar is a member of SHM.

Dr. Anvekar is in network with 14 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.